Exciting news from Magic! The company has successfully raised a whopping $200,000,000 in funding. Magic is revolutionizing the world of executive assistance by combining the power of artificial intelligence with human expertise. This substantial investment will be used to further develop and enhance their cutting-edge technology, enabling Magic to provide unparalleled support to their clients. With this new round of funding, Magic is poised to expand its reach and cement its position as a leader in the executive assistance industry. The company is thrilled about the opportunities this funding will unlock and is eager to continue pushing the boundaries of what is possible in the realm of AI-powered assistance.
Breaking News: Magic Secures $200 Million in Funding for Revolutionary AI-powered Executive Assistant Platform
Recently funded 路 $200.0MTechnology/Software
Get the full Magic company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
